CRWE & PWRM Investment Highlights !!!

LevelStock.com Newsletter

LevelStock.com Newsletter June 4th 2010.


Crown Equity Holdings, Inc. CRWE.OB

 

CRWE Investment  Highlights


***CRWE has expanded its internet footprint internationally to include the following 20 countries; Argentina, Australia, Brazil, Canada, China, France, French-Canadian, Germany, Hong Kong, India, Ireland, Italy, Japan, Korea, Mexico, New Zealand, Singapore, Spain, Taiwan and the UK.

***We are pleased by the dramatic improvement by the Company during the past year over the previous year," commented Kenneth Bosket, President and CEO of Crown Equity Holdings, Inc. "Through the dedication of our team and the support of our clients, we were able to have a banner year, as well as set the stage to continue our impressive growth into the future," stated Bosket.

About Crown Equity Holdings, Inc.

Crown Equity Holdings, Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.

For more information, go to:www.crownequityholdings.com.

____________________________________________________________________

Power 3 Medical Products Inc. PWRM.OB

 


PWRM Investment Highlights

 

***PWRM  has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the world's most prestigious peer-reviewed scientific journals.

***PWRM  also plans to demonstrate the clinical application and benefits of its NuroPro(R) diagnostic tests to healthcare providers located throughout the world.

***PWRM believes that this will assist the company greatly in an effort to generate sales of its NuroPro(R) diagnostic tests.

***PWRM is currently working on a joint distribution effort with a number of potential business partners, such as the companies mentioned above, for the sale of its NuroPro(R) diagnostic tests and the development of new drugs.

About Power3 Medical Products

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro(TM), a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro(R), a serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, currently engaged in Phase II clinical trials. These products are designed to analyze proteins and their mutations to assess an individual's risk for developing disease later in life, a patient's likelihood of responding to a particular drug, a patient's risk of disease progression and disease recurrence, to measure a patient's exposure to drug therapy, to ensure optimal dosing and reduced drug toxicity.

For more information, please visit http://www.power3medical.com.

  Stay Tuned. Happy Trading !

LevelStock.com